Taipei Exchange - Delayed Quote TWD

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

156.50
+0.50
+(0.32%)
At close: 1:30:12 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
948,402
933,813
758,391
627,512
438,841
Cost of Revenue
288,302
273,773
273,637
212,955
193,361
Gross Profit
660,100
660,040
484,754
414,557
245,480
Operating Expense
223,565
194,403
147,022
130,762
129,278
Operating Income
436,535
465,637
337,732
283,795
116,202
Net Non Operating Interest Income Expense
9,070
10,763
13,977
9,365
2,259
Pretax Income
525,813
460,744
623,014
264,103
396,821
Tax Provision
92,185
93,493
83,617
63,389
27,220
Net Income Common Stockholders
433,628
367,251
539,397
200,714
369,601
Diluted NI Available to Com Stockholders
433,628
367,251
539,397
200,714
369,601
Basic EPS
5.36
4.55
6.59
2.44
4.51
Diluted EPS
5.36
4.55
6.57
2.42
4.46
Basic Average Shares
81,177.35
80,673
81,803
82,396.60
82,032.39
Diluted Average Shares
81,177.35
80,720
82,075
82,914.70
82,792.03
Total Expenses
511,867
468,176
420,659
343,717
322,639
Net Income from Continuing & Discontinued Operation
433,628
367,251
539,397
200,714
369,601
Normalized Income
433,374.82
367,300.42
539,397
200,714
369,601
Interest Income
9,342
10,888
14,178
9,875
2,877
Interest Expense
272
125
201
510
618
Net Interest Income
9,070
10,763
13,977
9,365
2,259
EBIT
526,085
460,869
623,215
264,613
397,439
EBITDA
555,346
491,759
655,522
300,161
433,262
Reconciled Cost of Revenue
288,302
273,773
273,637
212,955
193,361
Reconciled Depreciation
29,261
30,890
32,307
35,548
35,823
Net Income from Continuing Operation Net Minority Interest
433,628
367,251
539,397
200,714
369,601
Total Unusual Items Excluding Goodwill
307
-62
0
--
--
Total Unusual Items
307
-62
0
--
--
Normalized EBITDA
555,039
491,821
655,522
300,161
433,262
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
53.82
-12.58
0
0
0
12/31/2021 - 10/26/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6733.TWO BioGend Therapeutics Co., Ltd.
31.00
0.00%
 
4162.TWO PharmaEngine, Inc.
85.50
-2.40%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
174.50
+0.87%
 
4743.TWO Oneness Biotech Co., Ltd.
57.60
+0.35%
 
6589.TWO EirGenix Inc.
63.70
+0.47%
 
4168.TWO GlycoNex Incorporation
26.00
-5.97%
 
4726.TWO Mycenax Biotech Inc.
40.30
+5.91%
 
6550.TW Polaris Group
39.90
-2.09%
 
4147.TWO TaiMed Biologics Inc.
81.80
+0.37%
 
6586.TWO CHO Pharma, Inc.
40.20
+0.12%